Burnout and Work-Life Balance in Radiation Oncology-AM2018
Professional burnout is characterized by emotional exhaustion, impersonal relationships with others, and a sense of professional inadequacy. Burnout is a common problem for oncologists who are expected to give care impartially to highly complex and very ill patients, often in a rigorous and stressful environment. This session is designed to raise awareness of burnout, identify how this could affect their practice, and provide strategies for mitigation of burnout such as improving work-life balance. To achieve these goals, Dr. Yechieli, Dr. De Bari, and Dr. Thomas will discuss their work identifying and defining burnout at different stages in the career of a radiation oncologist (training, early, and late). Dr. Jagsi will discuss her work on mitigation of burnout and work-life balance.
This activity is available from March 14, 2019, through 11:59 p.m. Eastern time on March 13, 2022.
This activity was originally recorded at ASTRO’s 2018 Annual Meeting, October 22-24, 2018 in San Antonio, TX.
The meeting is designed to meet the interests of radiation oncologists, medical oncologists, and nurses.
- Describe the features of professional burnout and identify burnout in themselves or others.
- Provide methods for mitigating burnout through means such as work-life balance.
Fei-Fei Liu, MD is employed by the Princess Margaret Cancer Centre and holds leadership positions at Princess Margaret Cancer Centre and the University of Toronto.
Eric Mellon, MD, PhD is employed by the University of Miami: Assistant Professor of Radiation Oncology, Compensation-ViewRay, Leadership-Neurologic Cancer Site Disease Group of the University of Miami Sylvester Cancer Center: Co-leader
Berardino De Bari is employed at the Université de Bourgogne - Franche Comté and has no financial relationships with a commercial interest.
Charles Thomas, MD is employed at the Oregon Health and Science University and has no financial relationships with a commercial interest.
Reshma Jagsi, MD, PhD, FASTRO is employed by the University of Michigan, receives compensation/remuneration/funding from Abbott and Abbvie Pharmaceuticals, American Cancer Society, Amgen, Breast Cancer Research Foundation, Doris Duke Foundation,Eviti, Greenwall Foundation, Michigan Radiation Oncology Quality Consortium, MROQC/Blue Cross Blue Shield of Michigan, NCCN, NIH, Susan Komen Foundation, and Vizient, holds ownership in Equity Quotient, and leadership position in ASCO.
Raphael Yechieli, MD is employed by the University of Miami and has nothing to disclose.
Additionally, the SA-CME Task Force and CME/MOC Committee had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.50 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.
- No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
- No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
- ASTRO staff cannot make modifications to your submitted materials.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.